The 2027 Financial Health Checklist for Cannabis Operators - Grab Your Seat for the Free Webinar Now!
The 2027 Financial Health Checklist for Cannabis Operators - Grab Your Seat for the Free Webinar Now!
Tag: CBT > DEA Cannabis Policy and Legalization | Cannabis Business Times
Subscribe
Sign In
Tag: CBT > DEA Cannabis Policy and Legalization: Page 2
Top Stories
DEA Names 25 Participants for Cannabis Rescheduling Hearing That’s Now Delayed Until 2025
An administrative law judge issued an order pushing back testimonies until January or February.
November 1, 2024
Cannabis Industry Research
Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling
The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.
September 20, 2024
Cannabis Advertising
The Complex Impact of Rescheduling Cannabis on Advertising
The penalties for advertising Schedule I drugs don’t apply to Schedule III drugs, but cannabis businesses could be left in a precarious position.
September 17, 2024
Industry Headlines
MMJ BioPharma Suing DEA Over Cannabis Reform, Medical Research
The biopharmaceutical company filed a lawsuit, citing ‘unjustified’ delays in processing an application for medical research.
September 11, 2024
2018 Farm Bill Status
4th Circuit Court Rules THC-O Meets Legal Definition of Hemp, Deviating From DEA
The federal court’s interpretation of the 2018 Farm Bill contradicts the Drug Enforcement Administration’s position that THC-O is illegal.
September 9, 2024
Texas
Allen Police Department, DEA Raid 9 Texas Vape Shops, Destroy Hemp Products
Local authorities accused the shops of selling noncompliant products, sometimes to minors. An attorney said the police and DEA ‘overstepped their authority.’
August 28, 2024
Cannabis Rescheduling
Cannabis Rescheduling No Longer on Fast Track; Hearing Scheduled For December
The DEA will not issue a final rule before the November election now that Administrator Anne Milgram granted an administrative law judge hearing.
August 27, 2024
Cannabis Rescheduling
Cannabis Rescheduling Nearly ‘Done Deal,’ Story Cannabis CEO Says
Jason Vedadi, the former executive chairman for Harvest Health before its acquisition by Trulieve, talks exclusively with CBT on what he expects from federal rescheduling as the industry awaits the DEA’s final determination.
July 29, 2024
Cannabis Rescheduling
43,000 Comments Filed on Cannabis Rescheduling Proposal as Public Period Closes
The Drug Enforcement Administration will now weigh these comments and potentially hold administrative law hearings before issuing a final rule.
July 23, 2024
Kentucky
Kentucky Governor Urges DEA to Reschedule: ‘The Jury is No Longer Out on Marijuana’
Gov. Andy Beshear wrote a letter to DEA Administrator Anne Milgram expressing his support for reclassifying cannabis to a Schedule III substance.
July 17, 2024
Cannabis Rescheduling
US Congressmen Press DEA Head to Explain Her Signature Absence on Cannabis Rescheduling Document
The agency’s administrator, Anne Milgram, did not personally approve the notice of proposed rulemaking to reclassify cannabis on May 16.
May 23, 2024
Banking Services Cannabis Industry
Federal Marijuana Rescheduling on the Horizon: A Big Step Forward But Not the Be-All-End-All
Rescheduling does not make cannabis legal throughout America and the U.S. territories; It makes cannabis a federally regulated medication—and many questions remain about the fate of the industry.
May 23, 2024
Previous Page
Page 2 of 8
Next Page